Eli Lilly's Mounjaro, a new diabetes and weight loss drug, is making waves in India. Approved by the drug regulator, this ...
Recently, the weight loss drug introduced by Eli Lilly, Mounjaro, has been launched in India sparking a debate among health experts ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...
While tariffs have triggered market volatility, certain pharmaceutical stocks still present strong investment opportunities.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果